How many drugs treat Ecthyma gangrenosum?

Drug Landscape tracks 2 marketed treatments for Ecthyma gangrenosum (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/ecthyma-gangrenosum.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-11 · How we verify

Ecthyma gangrenosum — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ecthyma gangrenosum (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Ecthyma gangrenosum, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Fortaz	CEFTAZIDIME	Pai Holdings Pharm	ceftazidime			1985-01-01
Ceftazidim	Ceftazidim	Tel-Aviv Sourasky Medical Center		Penicillin-binding protein 1A, Penicillin-binding protein 1B, Peptidoglycan synthase FtsI

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Pai Holdings Pharm · 2 drugs in Ecthyma gangrenosum
Tel-Aviv Sourasky Medical Center · 1 drug in Ecthyma gangrenosum

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Ecthyma gangrenosum:

Cite this brief

Drug Landscape (2026). Ecthyma gangrenosum — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/ecthyma-gangrenosum. Accessed 2026-06-11.

Ecthyma gangrenosum full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing